ISENTRESS Side Effects

7028398-9 | Abdominal Pain, Blood Creatinine Increased, Constipation, Endometriosis, Hydronephrosis, Lymphadenitis Viral, Lymphadenopathy, Ovarian Adenoma
on Sep 23, 2010 Female patient from UNITED STATES , 45 years of age, weighting 109.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood creatinine increased, constipation (What is constipation?), endometriosis (What is endometriosis?), hydronephrosis, lymphadenitis viral, lymphadenopathy, ovarian adenoma. Isentress dosage: 400 Mg Bid Po. During the same period patient was treated with DARUNAVIR UNK (600 Mg Bid Po) (View Darunavir Unk Review and Darunavir Unk Label ), ETRAVIRINE (200 Mg Bid Po) (View Etravirine Review and Etravirine Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (200/300 Mg Daily Po) (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), RITONAVIR (100 Mg Bid Po) (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

7026537-7 | Hodgkin's Disease, Lymphadenitis
Patient was taking Isentress (View Usage). Patient had the following side effects: hodgkin's disease (What is hodgkin's disease?), lymphadenitis on Sep 21, 2010 from INDIA Additional patient health information: Female patient , 28 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Isentress dosage: 400 Mg/bid, Po. During the same period patient was treated with TRUVADA (1 Tab/daily, Po) (View Truvada Review and Truvada Label ). Patient was hospitalized.

7023518-4 | Dyspnoea, Hepatic Failure, Hyperlactacidaemia, Insomnia, Metabolic Acidosis, Shock, Ventricular Arrhythmia
Adverse event was reported on Sep 27, 2010 by a Male patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), type 2 diabetes mellitus, pulmonary hypertension (What is pulmonary hypertension?), depression (What is depression?) and. Location: FRANCE , 53 years of age, After Isentress was administered, patient had the following side effects: dyspnoea, hepatic failure, hyperlactacidaemia, insomnia, metabolic acidosis, shock, ventricular arrhythmia. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), FOSAMPRENAVIR CALCIUM (View Fosamprenavir Calcium Review and Fosamprenavir Calcium Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), GLYBURIDE AND METFORMIN HYDROCHLORIDE (View Glyburide And Metformin Hydrochloride Review and Glyburide And Metformin Hydrochloride Label ), SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), ACEPROMETAZINE MALEATE AND MEPROBAMATE (View Aceprometazine Maleate And Meprobamate Review and Aceprometazine Maleate And Meprobamate Label ). Patient was hospitalized.

7021488-6 | Eosinophil Count Increased, Liver Function Test Abnormal, Rash
on Sep 24, 2010 Female patient from UNITED KINGDOM , 55 years of age, was diagnosed with hiv infection (What is hiv infection?), antifungal prophylaxis and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophil count increased, liver function test abnormal, rash (What is rash?). Isentress dosage: . During the same period patient was treated with CODEINE (View Codeine Review and Codeine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ). Patient was hospitalized.


7021487-4 | Eosinophilia, Pyrexia, Rash Erythematous, Thrombocytopenia
on Sep 24, 2010 Male patient from SPAIN , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient had the following side effects: eosinophilia, pyrexia, rash erythematous, thrombocytopenia. Isentress dosage: . During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), NORVIR (View Norvir Review and Norvir Label ), PREZISTA (View Prezista Review and Prezista Label ), TRUVADA (View Truvada Review and Truvada Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), REXER (View Rexer Review and Rexer Label ), IDALPREM (View Idalprem Review and Idalprem Label ). Patient was hospitalized.

7019253-9 | Hypotension, Pregnancy, Stillbirth, Urosepsis
Patient was taking Isentress (View Usage). After Isentress was administered, patient had the following side effects: hypotension, pregnancy (What is pregnancy?), stillbirth, urosepsis on Sep 15, 2010 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with acquired immunodeficiency syndrome and. Isentress dosage: 800 Mg/daily/po. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EMTRIVA (View Emtriva Review and Emtriva Label ), KALETRA (View Kaletra Review and Kaletra Label ), NORVIR (View Norvir Review and Norvir Label ), PREZISTA (View Prezista Review and Prezista Label ), VIREAD (View Viread Review and Viread Label ).

7018359-8 | Foetal Distress Syndrome, Stillbirth, Trisomy 21
Adverse event was reported on Sep 15, 2010 by a Male patient taking Isentress (View Usage) (Dosage: 800) was diagnosed with acquired immunodeficiency syndrome and. Location: UNITED STATES , weighting 1.82 lb, Patient experienced the following unwanted or unexpected effects: foetal distress syndrome, stillbirth, trisomy 21. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EMTRIVA (View Emtriva Review and Emtriva Label ), KALETRA (View Kaletra Review and Kaletra Label ), NORVIR (View Norvir Review and Norvir Label ), PREZISTA (View Prezista Review and Prezista Label ), VIREAD (View Viread Review and Viread Label ).

7015602-6 | Agranulocytosis, Anaemia, Dysphagia, Granulocytopenia, Neutropenia, Oral Disorder
on Sep 15, 2010 Male patient from SWITZERLAND , 47 years of age, weighting 110.2 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis, pain (What is pain?) and was treated with Isentress (View Usage). Patient had the following side effects: agranulocytosis, anaemia, dysphagia, granulocytopenia, neutropenia, oral disorder. Isentress dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), NORVIR (View Norvir Review and Norvir Label ), PREZISTA (View Prezista Review and Prezista Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), IRFEN (View Irfen Review and Irfen Label ). Patient was hospitalized.

7013245-1 | Aortic Disorder, Congenital Aortic Anomaly, Premature Baby, Pulmonary Hypoplasia, Small For Dates Baby, Ventricular Septal Defect
on Sep 13, 2010 Male patient from UNITED STATES , weighting 2.20 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). After Isentress was administered, patient had the following side effects: aortic disorder, congenital aortic anomaly, premature baby, pulmonary hypoplasia, small for dates baby, ventricular septal defect. Isentress dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ).

7009982-5 | Cholelithiasis, Pancreatitis, Transaminases Increased
Patient was taking Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: cholelithiasis, pancreatitis, transaminases increased on Sep 21, 2010 from FRANCE Additional patient health information: Male patient , 48 years of age, was diagnosed with hiv infection (What is hiv infection?), cerebrovascular accident and. Isentress dosage: . During the same period patient was treated with EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ). Patient was hospitalized.

7007818-X | Cleft Lip And Palate
Adverse event was reported on Sep 14, 2010 by a Male patient taking Isentress (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 6.61 lb, Patient had the following side effects: cleft lip and palate (What is cleft lip and palate?). During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RETROVIR (View Retrovir Review and Retrovir Label ).

7007231-5 | Hydronephrosis, Ovarian Cyst
on Sep 10, 2010 Female patient from UNITED STATES , 45 years of age, weighting 109.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). After Isentress was administered, patient had the following side effects: hydronephrosis, ovarian cyst (What is ovarian cyst?). Isentress dosage: 400 Mg/bid/po. During the same period patient was treated with DARUNAVIR UNK (600 Mg/bid/po) (View Darunavir Unk Review and Darunavir Unk Label ), ETRAVIRINE UNK (200 Mg/bid/po) (View Etravirine Unk Review and Etravirine Unk Label ), EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (200/300 Mg/daily/po) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), RITONAVIR (100 Mg/bid/po) (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

7007216-9 | Congenital Anomaly, Foetal Distress Syndrome, Stillbirth
on Sep 01, 2010 Male patient from UNITED STATES , weighting 1.82 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: congenital anomaly, foetal distress syndrome, stillbirth. Isentress dosage: 800. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EMTRIVA (View Emtriva Review and Emtriva Label ), KALETRA (View Kaletra Review and Kaletra Label ), NORVIR (View Norvir Review and Norvir Label ), PREZISTA (View Prezista Review and Prezista Label ), VIREAD (View Viread Review and Viread Label ).

7007214-5 | Abdominal Pain, Blood Creatinine Increased, Pelvic Mass
Patient was taking Isentress (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood creatinine increased, pelvic mass on Sep 05, 2010 from UNITED STATES Additional patient health information: Female patient , 45 years of age, weighting 109.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Isentress dosage: 400 Mg/bid/po. During the same period patient was treated with DARUNAVIR UNK (600 Mg/bid/po) (View Darunavir Unk Review and Darunavir Unk Label ), ETRAVIRINE UNK (200 Mg/bid/po) (View Etravirine Unk Review and Etravirine Unk Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (200/300 Mg/daily/po) (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), RITONAVIR (100 Mg/bid/po) (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

7007161-9 | Diabetes Mellitus Inadequate Control
Adverse event was reported on Sep 01, 2010 by a Male patient taking Isentress (View Usage) (Dosage: 800 Mg/daily, Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: JAPAN , 40 years of age, After Isentress was administered, patient had the following side effects: diabetes mellitus inadequate control. During the same period patient was treated with EFAVIRENZ (600 Mg/daily, Po; 600 Mg/daily, Po; 600 Mg/daily, Po) (View Efavirenz Review and Efavirenz Label ), EPIVIR (150 Mg/bid, Po; 300 Mg/daily, Po) (View Epivir Review and Epivir Label ), NORVIR (100 Mg/daily, Po; 100 Mg/daily, Po) (View Norvir Review and Norvir Label ), VIREAD (300 Mg/daily, Po) (View Viread Review and Viread Label ). Patient was hospitalized.

7007107-3 | Congenital Anomaly, Foetal Distress Syndrome, Stillbirth
on Sep 01, 2010 Female patient from UNITED STATES , 39 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: congenital anomaly, foetal distress syndrome, stillbirth. Isentress dosage: 800 Mg/daily;po. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), EMTRIVIA (View Emtrivia Review and Emtrivia Label ), KALETRA (View Kaletra Review and Kaletra Label ), NORVIR (View Norvir Review and Norvir Label ), PREZISTA (View Prezista Review and Prezista Label ), VIREAD (View Viread Review and Viread Label ).

7005709-1 | Diarrhoea
on Sep 10, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with hiv test positive (What is hiv test positive?) and was treated with Isentress (View Usage). Patient had the following side effects: diarrhoea. Isentress dosage: . Patient was hospitalized.

7005701-7 | Abdominal Pain, Cardiac Failure Congestive, Hemiparesis, Pancreatitis, Renal Failure, Weight Decreased
Patient was taking Isentress (View Usage). After Isentress was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cardiac failure congestive, hemiparesis, pancreatitis, renal failure, weight decreased on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Isentress dosage: . During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ). Patient was hospitalized and became disabled.

7001884-3 | Cerebrovascular Accident
Adverse event was reported on Sep 14, 2010 by a Male patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 72 years of age, weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. During the same period patient was treated with SOTALEX (View Sotalex Review and Sotalex Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), PLAVIX (View Plavix Review and Plavix Label ), CRESTOR (View Crestor Review and Crestor Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), TOPALGIC LP (View Topalgic Lp Review and Topalgic Lp Label ), DEXERYL CREAM (View Dexeryl Cream Review and Dexeryl Cream Label ). Patient was hospitalized.

7001878-8 | Atrial Fibrillation, Blood Creatinine Increased, Hypoglycaemia, Leukoplakia Oral, Melanocytic Naevus
on Sep 09, 2010 Male patient from UNITED STATES , 32 years of age, weighting 242.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood creatinine increased, hypoglycaemia, leukoplakia oral, melanocytic naevus. Isentress dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), SEBULEX (View Sebulex Review and Sebulex Label ), PREDNISONE (For 2 Days) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6986056-0 | Dyslipidaemia, Weight Increased
on Sep 13, 2010 Female patient from FRANCE , 51 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). After Isentress was administered, patient had the following side effects: dyslipidaemia, weight increased. Isentress dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6986055-9 | Aortic Valve Disease, Aortic Valve Sclerosis, Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Anomaly, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder
Patient was taking Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve disease, aortic valve sclerosis, apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital anomaly, congenital heart valve disorder, congenital pulmonary valve disorder on Sep 13, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 6.61 lb, was diagnosed with hiv infection (What is hiv infection?) and. Isentress dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ).

6985574-9 | Anal Atresia, Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Genital Malformation, Erythema, Exomphalos
Adverse event was reported on Sep 09, 2010 by a Female patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), gestational diabetes and. Location: UNITED KINGDOM , weighting 4.41 lb, Patient had the following side effects: anal atresia, bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital genital malformation, erythema, exomphalos. During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), TIPRANAVIR (View Tipranavir Review and Tipranavir Label ), INSULIN (View Insulin Review and Insulin Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized and became disabled.

6985561-0 | Premature Labour
on Sep 09, 2010 Female patient from UNITED KINGDOM , 42 years of age, was diagnosed with hiv infection (What is hiv infection?), gestational diabetes and was treated with Isentress (View Usage). After Isentress was administered, patient had the following side effects: premature labour. Isentress dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), TIPRANAVIR (View Tipranavir Review and Tipranavir Label ), INSULIN (View Insulin Review and Insulin Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

6981109-5 | Deafness Neurosensory, Tinnitus
on Sep 08, 2010 Male patient from UNITED STATES , 53 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: deafness neurosensory, tinnitus (What is tinnitus?). Isentress dosage: .

6979599-7 | Renal Tubular Necrosis
Patient was taking Isentress (View Usage). Patient had the following side effects: renal tubular necrosis on Sep 08, 2010 from FRANCE Additional patient health information: Male patient , 47 years of age, was diagnosed with hiv infection (What is hiv infection?), acute lymphocytic leukaemia and. Isentress dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CELSENTRI (View Celsentri Review and Celsentri Label ), TRUVADA (View Truvada Review and Truvada Label ), DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6978942-2 | Pancreatitis
Adverse event was reported on Sep 03, 2010 by a Female patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 29 years of age, After Isentress was administered, patient had the following side effects: pancreatitis. Patient was hospitalized.

6977561-1 | Hyperglycaemia
on Sep 08, 2010 Male patient from FRANCE , 53 years of age, was diagnosed with hiv infection (What is hiv infection?), type 2 diabetes mellitus and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia. Isentress dosage: . During the same period patient was treated with ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), METFORMIN (View Metformin Review and Metformin Label ), VILDAGLIPTIN (View Vildagliptin Review and Vildagliptin Label ).

6977558-1 | Hyperglycaemia
on Sep 08, 2010 Male patient from FRANCE , 53 years of age, was diagnosed with hiv infection (What is hiv infection?), type 2 diabetes mellitus and was treated with Isentress (View Usage). Patient had the following side effects: hyperglycaemia. Isentress dosage: . During the same period patient was treated with ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), METFORMIN (View Metformin Review and Metformin Label ), VILDAGLIPTIN (View Vildagliptin Review and Vildagliptin Label ).

6977102-9 | Depression
Patient was taking Isentress (View Usage). After Isentress was administered, patient had the following side effects: depression (What is depression?) on Sep 01, 2010 from CANADA Additional patient health information: Male patient , 54 years of age, . Isentress dosage: . During the same period patient was treated with BUPROPION HYDROCHLORIDE (View Bupropion Hydrochloride Review and Bupropion Hydrochloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), KALETRA (View Kaletra Review and Kaletra Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), REYATAZ (View Reyataz Review and Reyataz Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), SUSTIVA (View Sustiva Review and Sustiva Label ).

6977100-5 | Nephropathy, Nephropathy Toxic, Renal Impairment
Adverse event was reported on Aug 20, 2010 by a Male patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), hypertension, arthralgia and. Location: AUSTRALIA , 49 years of age, weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: nephropathy, nephropathy toxic, renal impairment. During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), INDOCIN (View Indocin Review and Indocin Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ).

6977084-X | Abortion Induced
on Sep 06, 2010 Female patient from FRANCE , 35 years of age, weighting 205.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient had the following side effects: abortion induced. Isentress dosage: .

6973440-4 | Cerebral Ataxia
on Sep 02, 2010 Female patient from UNITED STATES , 56 years of age, weighting 154.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). After Isentress was administered, patient had the following side effects: cerebral ataxia. Isentress dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), BUPROPION HYDROCHLORIDE (View Bupropion Hydrochloride Review and Bupropion Hydrochloride Label ). Patient was hospitalized and became disabled.

6971791-0 | Nephropathy, Nephropathy Toxic, Renal Impairment
Patient was taking Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: nephropathy, nephropathy toxic, renal impairment on Sep 02, 2010 from AUSTRALIA Additional patient health information: Male patient , 49 years of age, weighting 160.9 lb, was diagnosed with hiv infection (What is hiv infection?), hypertension, arthralgia and. Isentress dosage: . During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), INDOCIN (View Indocin Review and Indocin Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ).

6971152-4 | Anal Atresia, Bladder Agenesis, Blood Iron Decreased, Caudal Regression Syndrome, Cloacal Exstrophy, Congenital Genital Malformation, Erythema, Exomphalos
Adverse event was reported on Sep 03, 2010 by a Female patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , weighting 4.41 lb, Patient had the following side effects: anal atresia, bladder agenesis, blood iron decreased, caudal regression syndrome, cloacal exstrophy, congenital genital malformation, erythema, exomphalos. During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), TIPRANAVIR (View Tipranavir Review and Tipranavir Label ), INSULIN (View Insulin Review and Insulin Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized and became disabled.

6971151-2 | Osteonecrosis
on Sep 01, 2010 Male patient from FRANCE , 47 years of age, was diagnosed with hiv infection (What is hiv infection?), herpes simplex (What is herpes simplex?) and was treated with Isentress (View Usage). After Isentress was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). Isentress dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), VALACYCLOVIR HYDROCHLORIDE (View Valacyclovir Hydrochloride Review and Valacyclovir Hydrochloride Label ).

6969444-8 | Pancreatitis Acute
on Sep 01, 2010 Female patient from FRANCE , 25 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Isentress dosage: . During the same period patient was treated with EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), VALGANCICLOVIR HYDROCHLORIDE (View Valganciclovir Hydrochloride Review and Valganciclovir Hydrochloride Label ), ATOVAQUONE (View Atovaquone Review and Atovaquone Label ), CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), NEFOPAM HYDROCHLORIDE (View Nefopam Hydrochloride Review and Nefopam Hydrochloride Label ), MORPHINE (View Morphine Review and Morphine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6968727-5 | Dysarthria
Patient was taking Isentress (View Usage). Patient had the following side effects: dysarthria on Sep 01, 2010 from SWITZERLAND Additional patient health information: Male patient , 51 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Isentress dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), INTELENCE (View Intelence Review and Intelence Label ). Patient was hospitalized.

6968725-1 | Eosinophilia, Pyrexia, Rash Erythematous, Thrombocytopenia
Adverse event was reported on Sep 01, 2010 by a Male patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , 43 years of age, After Isentress was administered, patient had the following side effects: eosinophilia, pyrexia, rash erythematous, thrombocytopenia. During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6965729-X | Nephropathy, Nephropathy Toxic, Renal Impairment
on Aug 20, 2010 Male patient from AUSTRALIA , 49 years of age, weighting 160.9 lb, was diagnosed with hiv infection (What is hiv infection?), hypertension, arthralgia and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: nephropathy, nephropathy toxic, renal impairment. Isentress dosage: . During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), INDOCIN (View Indocin Review and Indocin Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ).

6964701-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Chloride Increased, Blood Lactate Dehydrogenase Increased, Blood Potassium Decreased, Blood Sodium Increased, Haematocrit Decreased, Haemoglobin Decreased
on Aug 23, 2010 Male patient from JAPAN , 59 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood chloride increased, blood lactate dehydrogenase increased, blood potassium decreased, blood sodium increased, haematocrit decreased, haemoglobin decreased. Isentress dosage: 800 Mg/daily Po. During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), TRUVADA (View Truvada Review and Truvada Label ).

6963891-6 | Femoral Arterial Stenosis, Peripheral Ischaemia
Patient was taking Isentress (View Usage). After Isentress was administered, patient had the following side effects: femoral arterial stenosis, peripheral ischaemia on Aug 26, 2010 from PORTUGAL Additional patient health information: Female patient , 14 years of age, weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Isentress dosage: . During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ). Patient was hospitalized.

6963255-5 | Eosinophilia, Hepatic Function Abnormal, Rash, Renal Impairment
Adverse event was reported on Aug 25, 2010 by a Male patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, hepatic function abnormal, rash (What is rash?), renal impairment. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized and became disabled.

6963253-1 | Cerebral Ataxia
on Aug 26, 2010 Female patient from UNITED STATES , 56 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient had the following side effects: cerebral ataxia. Isentress dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized and became disabled.

6958551-1 | Pancreatitis Acute
on Aug 26, 2010 Male patient from FRANCE , 49 years of age, was diagnosed with hiv infection (What is hiv infection?), type 2 diabetes mellitus and was treated with Isentress (View Usage). After Isentress was administered, patient had the following side effects: pancreatitis acute. Isentress dosage: . During the same period patient was treated with EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6956869-X | Myopathy, Oedema Peripheral
Patient was taking Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: myopathy, oedema peripheral on Aug 26, 2010 from IRELAND Additional patient health information: Male patient , 68 years of age, weighting 154.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Isentress dosage: . During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ). Patient was hospitalized and became disabled.

6955959-5 | Anaphylactic Reaction, Hypersensitivity, Hypoaesthesia Oral, Paraesthesia
Adverse event was reported on Aug 26, 2010 by a Male patient taking Isentress (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: GREECE , 41 years of age, weighting 191.8 lb, Patient had the following side effects: anaphylactic reaction, hypersensitivity, hypoaesthesia oral, paraesthesia. During the same period patient was treated with ABACAVIR SULFATE AND LAMIVUDINE (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ). Patient was hospitalized.

6945664-3 | Nephropathy, Nephropathy Toxic, Renal Impairment
on Aug 20, 2010 Male patient from AUSTRALIA , 49 years of age, weighting 160.9 lb, was diagnosed with hiv infection (What is hiv infection?), hypertension, arthralgia and was treated with Isentress (View Usage). After Isentress was administered, patient had the following side effects: nephropathy, nephropathy toxic, renal impairment. Isentress dosage: . During the same period patient was treated with INTELENCE (View Intelence Review and Intelence Label ), PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), INDOCIN (View Indocin Review and Indocin Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ).

6945644-8 | Peripheral Ischaemia
on Aug 25, 2010 Female patient from PORTUGAL , 14 years of age, weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Isentress (View Usage). Patient experienced the following unwanted or unexpected effects: peripheral ischaemia. Isentress dosage: . During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

6945643-6 | Adrenal Cyst
Patient was taking Isentress (View Usage). Patient had the following side effects: adrenal cyst on Aug 24, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 6.61 lb, . Isentress dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), KALETRA (View Kaletra Review and Kaletra Label ), VIREAD (View Viread Review and Viread Label ).